The Medicare Prescription Drug Rebate Rule

Keep Reading

Extending Market Exclusivity Periods

There is no excerpt because this is a protected post.

Keep Reading

The Low Cost of Generic Tadalafil Prescription Medication

Main Information On Tadalafil Principle of Action Tadalafil is the main active ingredient of Cialis, one of the most popular drugs for erectile dysfunction (ED) today. This substance is responsible for the effect of Cialis on the male body. How is the effect of the drug achieved, which allows to improve potency and get rid...

Keep Reading

National Online Survey of Seniors Regarding the Medicare Part D Prescription Drug Benefit

There is no excerpt because this is a protected post.

Keep Reading

Pharmacy Services Administrative Organizations (PSAOs) and their Little-Known Connections to Independent Pharmacies

Keep Reading

Podcast: The Impact of COVID-19 on the Pharmaceutical Market

JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare – and human health – forward. JC Scott: Welcome to The Pharmacy Benefit, a podcast...

Keep Reading

Key Findings from Survey of Benefit Managers

Our national survey of benefit managers and human resources directors, conducted online June 4-9, 2020, consists of 250 respondents drawn from a list of benefit managers and human resources directors provided by Dynata. All respondents work for a company with 1,000 or more employees, have at least 1,000 individuals under coverage, and have an annual...

Keep Reading

Just the Facts: Pharmacy Direct and Indirect Remuneration Increases Value and Improves Quality

During the Energy and Commerce Health Subcommittee hearing on “The Fiscal Year 2021 HHS Budget and Oversight of the Coronavirus Outbreak” several inaccurate remarks were made on pharmacy direct and indirect remuneration (DIR). What is Pharmacy DIR? Pharmacy benefit managers (PBMs) and Part D plan sponsors use pharmacy DIR to create high-quality, value-based pharmacy networks,...

Keep Reading

Response to XIL Consulting’s “Payers and PBMs Profit from Obscure Pharmacy Fees, While Seniors See No Relief in Prescription Costs”

A recent blog (“Payers and PBMs Profit from Obscure Pharmacy Fees, While Seniors See No Relief in Prescription Costs”) suggests performance-based price concessions are retained by PBMs, restrict the growth of independent pharmacies, and inflate Medicare Part D enrollee’s out-of-pocket costs—unfounded suggestions that evidence does not support.[1] Performance-based Pharmacy Reimbursement Saves Taxpayer Dollars and Helps Lower...

Keep Reading

The Medicare Prescription Drug Rebate Rule

Keep Reading